OCS News in Full
Emerald Health Therapeutics Continues to Grow Sales with First Cannabis Shipment to Ontario Cannabis Retail Corporation Ontario marks a key province to offer Emerald-branded cannabis products, expanding Emeralds market opportunity to over half of the Canadian cannabis-consuming population
VICTORIA, British Columbia, March 14, 2019 -- Emerald Health Therapeutics, Inc. ("Emerald" or the Company) (TSXV:EMH; OTCQX:EMHTF) has fulfilled its first purchase order of cannabis from Ontario Cannabis Retail Corporation, operating as the Ontario Cannabis Store (OCS).
As we scale up production in our wholly-owned, premium indoor growing facility, Verdlite, and our large-scale, state-of-the-art joint venture greenhouse operation, Pure Sunfarms, we are consistently meeting our supply commitments of Emerald-branded adult-use cannabis in British Columbia and Newfoundland Labrador, and we are now prepared to provide the same service to the Ontario Cannabis Retail Corporation and other provinces, said Dr. Avtar Dhillon, President and Executive Chairman of Emerald. We now have distribution access to over half of the Canadian population of adult-users of non-medical cannabis. We are advancing prospective supply agreements that we expect will ultimately give us nation-wide market exposure.
Currently, Emeralds cannabis supply is provided primarily through its 88,000 sq. ft. Verdlite indoor facility in Saint Eustache, Quebec, and through Pure Sunfarms, its 50%-owned 1.1 million sq. ft. greenhouse facility in Delta, British Columbia. It is working to expand sources and volume of indoor, greenhouse and outdoor-grown cannabis and cannabinoid products. In 2018, Emerald acquired 500 acres of harvested hemp and expects to purchase approximately 1,000 acres of harvested hemp in 2019. It is implementing steps intended to achieve large-scale extraction and softgel encapsulation of cannabis products.
Emerald-branded products are expected to be available through the OCS next week.